Tradestie Institutional Equity Comparison Engine

EQ vs STTK โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

EQ Overall Edge

EQ Captures Institutional Edge (2โ€“1 Pillars ยท 3โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Equillium, Inc. Common Stock (EQ) driven by superior Valuation, Options & Structure while STTK counters with relative strength in Momentum & Technical. Fundamentally, EQ trades at 1.5x Forward P/E with 0.0% operating margin (-52.3% YoY revenue) versus STTK at N/M Forward P/E and 0.0% operating margin (-66.6% YoY). In options structure, EQ sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro) against STTK sits in BREAKDOWN (10th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner EQ
EQ 1.5x vs STTK N/M Fwd P/E
Growth & Margin Winner Tie
Op Margin 0.0% vs 0.0% ยท YoY -52.3% vs -66.6%
Momentum & Technical Winner STTK
1Y +12.0% vs +126.4% ยท 52W Pos 11% vs 41%
Options & Structure Winner EQ
UNCLASSIFIED (100th %ile IV) vs BREAKDOWN (10th %ile IV)
EQ NASDAQ
Equillium, Inc. Common Stock
Pharmaceutical Preparations
$1.12
+1.82% 1D
Market Cap $90.6M
1M Return -21.13%
1Y Return +12.0%
Forward P/E 1.5x
Unified AI Score
48.0 / 100 HOLD
Tech 30.0 Fund 51.0 Flow 63.0 Mom 60.0
STTK NASDAQ
Shattuck Labs, Inc. Common Stock
Pharmaceutical Preparations
$4.55
+1.79% 1D
Market Cap $459.8M
1M Return -18.46%
1Y Return +126.37%
Forward P/E N/M
Unified AI Score
58.4 / 100 HOLD
Tech 82.0 Fund 50.0 Flow 63.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: EQ +12.0% STTK +126.37% Spread: +114.37 pp (STTK Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period EQ Revenue STTK Revenue EQ Op. Margin STTK Op. Margin Margin Edge
FY2019 N/A $10M N/A -253.5% STTK
FY2020 N/A $10M N/A -371.8% STTK
FY2021 N/A $30M N/A -150.8% STTK
FY2022 $20M $0M -393.9% -15848.0% EQ
FY2023 $40M $0M -40.2% -5549.6% EQ
FY2024 $40M $10M -20.1% -1408.3% EQ
FY2025 N/A $0M N/A -5150.8% STTK

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: EQ (3) vs STTK (5)
Institutional Metric EQ STTK Criterion Row Winner
Market Capitalization Scale $90.6M $459.8M Larger Scale STTK
Trailing P/E Ratio Valuation 1.5x N/M Lower Multiple EQ
Forward P/E Ratio Valuation 1.5x N/M Lower Multiple EQ
Revenue Growth (YoY) Growth -52.3% -66.6% Higher Growth EQ
Operating Margin (TTM) Profitability 0.0% 0.0% Higher Margin Tie
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -59.0% -47.2% Higher ROE STTK
52-Week Range Position Momentum 11% ($1โ€“$4) 41% ($2โ€“$8) Stronger Trend STTK
Beta / 30D Volatility Risk Regime 1.53ฮฒ ยท 93% Vol 1.46ฮฒ ยท 68% Vol Lower Realized Risk STTK
Unified Institutional Score Composite Signal 48.0 / 100 (HOLD) 58.4 / 100 (HOLD) Higher Composite STTK

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full EQ vs STTK Buy Guide
EQ UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 100th %ile
IV Regime Extreme (>80th %ile)
Live EQ Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
STTK BREAKDOWN
61d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 10th %ile
IV Regime Compressed (<25th %ile)
Live STTK Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither EQ nor STTK registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.